Lauren Rusckowski Duprey

All filings by Lauren Rusckowski Duprey on record concern Takeda Pharmaceutical Co Ltd. We count 4 filings; the first trade dates from 27 April 2026 and the latest from 14 September 2026.

No open-market purchase appears, only 2 sales worth €1.3M. The rest of the record consists of 2 share grants.

Most recently, on 15 September 2026, the filings show an open-market sale worth €552k in Takeda Pharmaceutical Co Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.